GR3018565T3 - Agent for the treatment of disorders of the cerebral neurotransmitter system - Google Patents
Agent for the treatment of disorders of the cerebral neurotransmitter systemInfo
- Publication number
- GR3018565T3 GR3018565T3 GR950403702T GR950403702T GR3018565T3 GR 3018565 T3 GR3018565 T3 GR 3018565T3 GR 950403702 T GR950403702 T GR 950403702T GR 950403702 T GR950403702 T GR 950403702T GR 3018565 T3 GR3018565 T3 GR 3018565T3
- Authority
- GR
- Greece
- Prior art keywords
- disorders
- agent
- treatment
- neurotransmitter system
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6414889 | 1989-03-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3018565T3 true GR3018565T3 (en) | 1996-03-31 |
Family
ID=13249705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR950403702T GR3018565T3 (en) | 1989-03-15 | 1995-12-29 | Agent for the treatment of disorders of the cerebral neurotransmitter system |
Country Status (9)
Country | Link |
---|---|
US (1) | US5087627A (el) |
EP (1) | EP0388081B1 (el) |
JP (1) | JPH082875B2 (el) |
KR (1) | KR900014345A (el) |
AT (1) | ATE132038T1 (el) |
DE (1) | DE69024385T2 (el) |
DK (1) | DK0388081T3 (el) |
ES (1) | ES2084657T3 (el) |
GR (1) | GR3018565T3 (el) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3831993A1 (de) * | 1988-09-21 | 1990-03-29 | Basf Ag | 2-hydroxy-3-phenoxy-propyl-substituierte piperazine und homo-piperazine, ihre herstellung und verwendung |
US5314885A (en) * | 1992-09-11 | 1994-05-24 | Mcneilab, Inc. | Cyclic benzylamino, benzylamido, and benzylimido antipsychotic agents |
GB9305282D0 (en) * | 1993-03-15 | 1993-05-05 | Ucb Sa | Enantiomers of 1-(4-chlorophenyl)phenylmethyl)-4-(4-methylphenyl)sulphonyl)piperazine |
JP3077047B2 (ja) * | 1993-04-16 | 2000-08-14 | 参天製薬株式会社 | 新規ピペラジン誘導体 |
DK0790236T3 (da) * | 1996-02-13 | 2004-02-23 | Pfizer | Prolægemidler af 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chlor-1,3-dihydro-2H-indol-2-on |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB863180A (en) * | 1957-12-17 | 1961-03-15 | Scient Res I For Practical Lif | Laevo-1:2-diphenyl-1-dimethylaminoethane and acid addition salts thereof |
JPS5247514B2 (el) * | 1972-10-07 | 1977-12-02 | ||
US3957788A (en) * | 1974-01-23 | 1976-05-18 | Dainippon Pharmaceutical Co., Ltd. | 1-substituted-4-(1,2-diphenylethyl)piperazine derivatives and their salts and the preparation thereof |
GB1545094A (en) * | 1976-12-14 | 1979-05-02 | Gist Brocades Nv | Piperazine derivatives |
NZ202665A (en) * | 1981-12-02 | 1986-04-11 | Ferrosan Ab | Diphenylbutyl-1-piperazinocarboxylate derivatives and pharmaceutical compositions |
GB8320701D0 (en) * | 1983-08-01 | 1983-09-01 | Wellcome Found | Chemotherapeutic agent |
JPH0745471B2 (ja) * | 1986-12-04 | 1995-05-17 | 参天製薬株式会社 | ピペラジン誘導体 |
JP2683670B2 (ja) * | 1988-06-28 | 1997-12-03 | 雅春 吐前 | ボウリング球の親指抜き装置 |
JP2506415B2 (ja) * | 1988-07-29 | 1996-06-12 | 富士写真フイルム株式会社 | カメラ一体型vtrおよびビデオカメラ |
EP0408782A1 (en) * | 1989-07-18 | 1991-01-23 | Nauchnoissledovatelski Chimikopharmatzevtichen Institut | Antihypoxic agent |
-
1990
- 1990-02-28 US US07/486,542 patent/US5087627A/en not_active Expired - Fee Related
- 1990-03-07 JP JP2057661A patent/JPH082875B2/ja not_active Expired - Lifetime
- 1990-03-08 EP EP90302479A patent/EP0388081B1/en not_active Expired - Lifetime
- 1990-03-08 ES ES90302479T patent/ES2084657T3/es not_active Expired - Lifetime
- 1990-03-08 DK DK90302479.2T patent/DK0388081T3/da active
- 1990-03-08 DE DE69024385T patent/DE69024385T2/de not_active Expired - Fee Related
- 1990-03-08 AT AT90302479T patent/ATE132038T1/de not_active IP Right Cessation
- 1990-03-15 KR KR1019900003504A patent/KR900014345A/ko active IP Right Grant
-
1995
- 1995-12-29 GR GR950403702T patent/GR3018565T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE69024385D1 (de) | 1996-02-08 |
JPH037229A (ja) | 1991-01-14 |
EP0388081A2 (en) | 1990-09-19 |
KR900014345A (ko) | 1990-10-23 |
ES2084657T3 (es) | 1996-05-16 |
JPH082875B2 (ja) | 1996-01-17 |
EP0388081B1 (en) | 1995-12-27 |
DK0388081T3 (da) | 1996-01-29 |
US5087627A (en) | 1992-02-11 |
EP0388081A3 (en) | 1992-03-04 |
DE69024385T2 (de) | 1996-05-30 |
ATE132038T1 (de) | 1996-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0184206A3 (en) | Vitamin d3 derivatives having a substituent at 2-position | |
DE3370585D1 (en) | Use of aminophenylacetic acid derivatives for the manufacture of an immunomodulating medical preparation | |
HUT40101A (en) | Process for producing quinolin-carboxylic acid derivatives and pharmaceutical compositions containing them as active agents | |
SG49607A1 (en) | 1-methylcarbapenem derivatives and process for preparation thereof | |
PH25910A (en) | Pyridine derivative and therapeutic agents for ulcer comprising the same | |
PL309874A1 (en) | Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives | |
GR3018565T3 (en) | Agent for the treatment of disorders of the cerebral neurotransmitter system | |
AU575197B2 (en) | 2-(3,5-dislkyl -4- hydroxyphenyl) indole derivatives | |
HUT58269A (en) | Process for producing aralkyl-amine derivatives and pharmaceutical compositions containing them as active components | |
AU6063298A (en) | Benzamide derivative, anti-ulcer drug, and antibacterial drug | |
ES2039485T3 (es) | Un procedimiento para la preparacion de un compuesto 3,4-dihidropirimidina n-sustituido. | |
EP0285284A3 (en) | N-phenethylaminoalkyl-benzamide anti-arrhythmia agents | |
IE901104L (en) | New bronchospasmolytic compounds and process for their¹preparation | |
IE811212L (en) | Substituted phenoxy-aminopropanol derivatives | |
EP0401715A3 (en) | Aminoketone compounds | |
HUT47923A (en) | Process for production of new derivatives of naphtotiazephin and medical compositions containing these substances | |
TW275629B (el) | ||
EP0372409A3 (en) | Acylaminoalkylpyridineamides as inhibitors of tumor metastasis | |
EP0272849A3 (en) | Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases | |
PH23966A (en) | Imidazoquinozoline compounds as agent for treatment of nephritis | |
ATE309212T1 (de) | Optisch aktive 1-phenylpyrrolidonderivate |